Package 51662-1359-1

Brand: 0.9% sodium chloride

Generic: 0.9% sodium chloride
NDC Package

Package Facts

Identity

Package NDC 51662-1359-1
Digits Only 5166213591
Product NDC 51662-1359
Product ID 51662-1359_2b39daef-65ee-0aa7-e063-6394a90a364d
Description

50 mL in 1 VIAL, PLASTIC (51662-1359-1)

Marketing

Marketing Status
Marketed Since 2019-07-18
Brand 0.9% sodium chloride
Generic 0.9% sodium chloride
Sample Package No

Linked Drug Pages (1)

0.9% SODIUM CHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "2b39daef-65ee-0aa7-e063-6394a90a364d", "openfda": {"unii": ["451W47IQ8X"], "rxcui": ["1807631"], "spl_set_id": ["8dfb05c0-77e8-2fa1-e053-2a95a90a3d33"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 VIAL, PLASTIC (51662-1359-1)", "package_ndc": "51662-1359-1", "marketing_start_date": "20190718"}], "brand_name": "0.9% SODIUM CHLORIDE", "product_id": "51662-1359_2b39daef-65ee-0aa7-e063-6394a90a364d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "51662-1359", "generic_name": "0.9% SODIUM CHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "0.9% SODIUM CHLORIDE", "active_ingredients": [{"name": "SODIUM CHLORIDE", "strength": "9 mg/mL"}], "application_number": "NDA018803", "marketing_category": "NDA", "marketing_start_date": "20190718", "listing_expiration_date": "20261231"}